Sterling Professor of Immunobiology and Professor of Dermatology and of Molecular, Cellular, and Developmental Biology and of Epidemiology (Microbial Diseases); Investigator, Howard Hughes Medical Institute, (HHMI)
Dr. Bornali Bhattacharjee, MS, PhD is a Research Associate Scientist at the Department of Immunobiology and the Associate Director at the Center for Infection & Immunity. Her role is to lead, coordinate and manage biomedical research projects that are geared towards understanding the immune trajectories of post-acute infection syndromes. Her training and research interests lie at the interface of pathogen genomics, evolutionary biology and host-pathogen interaction. She earned her PhD in Molecular Epidemiology & Virology from Indian Statistical Institute & University of Calcutta. Her post-doctoral training was in Viral Genomics & Evolution at University of Massachusetts Medical School.
Simone Blaser an Infectious Disease fellow at Yale University. She is currently performing post-doctoral research in the laboratory of Dr. Akiko Iwasaki in the Department of Immunobiology at Yale, where she is exploring oral host-microbe interactions in Long COVID. She completed residency in Internal Medicine at New York University. She has been published in CID, JAMA, MBio, Diagnosis, JAMA, Clinical Correlations, and Intima: A Journal of Narrative Medicine. Prior to becoming a physician, she worked in book publishing, where she was involved in developing what would become the #1 New York Times bestseller When Breath Becomes Air with the late Dr. Paul Kalanithi. Her poetry was included in a collection on New York City haiku published by The New York Times.
Dr. Gehlhausen is a dermatologist and physician-scientist in Dr. Iwasaki's lab working on autoimmune connective tissue diseases affecting the skin, including lupus erythematosus. His focus is on how type I interferons, which are essential innate antiviral pathways, mediate the pathophysiology of lupus disease. Though the association of type I interferons and lupus has been well established, the precise mechanism of how and which cell types mediate pathologic changes remains incompletely understood. Dr. Gehlhausen has a connective tissue disease clinic where he sees complex autoimmune cases and utilizes high dimensional techniques like single cell rna sequencing to profile the skin manifestations of these patients. Additionally, he makes heavy use of genetic mouse models of try to better understand the cellular and molecular effectors driving type I interferon...
I grew up in Southern California and graduated from USC. I spent a few years doing computational cancer genomics research which eventually led me to the interface of genomics and tumor immunology. I am currently interested in the intersection of cancer biology, immunology, and machine learning to improve and/or develop novel therapies for cancer patients. Outside of research and medicine, I spend my time playing soccer on the club team here at Yale, playing pick-up basketball with classmates, and eating (probably too many) chocolate chip cookies.
I graduated from the Massachusetts Institute of Technology (MIT) with a double major in Biological Engineering and Brain & Cognitive Sciences. In the past, I studied infant social cognition using functional near-infrared spectroscopy in the Saxe Lab at MIT. At the Mayo Clinic, I led a protein engineering project working with tissue inhibitor of metalloproteinases-1 (TIMP-1) to alter the inhibitory profile toward cancer biomarkers, matrix metalloproteinases (MMPs).
Moving forward, I will continue to pursue cancer research, specifically tumor immunology, immunotherapy, and neuro-immunology.
Fun fact: I was invited to train at the United States Olympic Training Center in Colorado Springs, CO for volleyball!